Hypotension
📧 Sign up to get email alerts when something new happens for Hypotension.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-07-04EMA Authorised: Neoatricon (dopamine hydrochloride;Dopamine) — BrePco Biopharma Limited
The European Medicines Agency authorised Neoatricon, a dopamine hydrochloride product, for the treatment of hypotension in the European Unio…
-
FDA approval · 2025-05-30FDA Approved: PHENYLEPHRINE HYDROCHLORIDE INJECTION, SOLUTION — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved phenylephrine hydrochloride injection, solution from Dr. Reddy's Laboratories Inc. as an Original Application. The product is i…
-
FDA approval · 2025-03-21FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (BIOCON PHARMA INC.)
FDA approved Biocon Pharma Inc. for an Original Application of norepinephrine bitartrate (norepinephrine bitartrate) as a generic product. I…
-
FDA approval · 2025-01-31FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' norepinephrine bitartrate as an original application (generic) product.
-
FDA approval · 2024-12-03FDA Approved: NOREPINEPHRINE — Supplemental Application (Long Grove Pharmaceuticals, LLC)
FDA approved a supplemental application for norepinephrine bitartrate (NOREPINEPHRINE) from Long Grove Pharmaceuticals, LLC under NDA 214628…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-05FDA Approved: DOPAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for dopamine hydrochloride injectable from Hikma Pharmaceuticals USA Inc., confirming continued appr…
-
FDA approval · 2024-10-03FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved an original ANDA for Isoproterenol hydrochloride from Sagent Pharmaceuticals.
-
EMA approval · 2024-09-25EMA Authorised: Giapreza (angiotensin II acetate) — Paion Pharma GmbH
Giapreza (angiotensin II acetate) has been authorised by the EMA for adults with hypotension and shock, under Paion Pharma GmbH, with a deci…
-
FDA approval · 2024-06-11FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for norepinephrine bitartrate from Baxter Healthcare Corporation.
-
FDA approval · 2024-05-13FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic norepinephrine bitartrate injection under an original ANDA from Rising Pharma Holdings, Inc. for use in the managemen…
-
FDA approval · 2024-04-12FDA Approved: BIORPHEN — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for BIORPHEN (phenylephrine hydrochloride) from Dr. Reddy's Laboratories Inc., updating/adding label…
-
FDA approval · 2024-03-14FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Method Pharmaceuticals, LLC)
FDA approved an Original Application for Phenylephrine hydrochloride from Method Pharmaceuticals, LLC.
-
FDA approval · 2023-09-15FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (NorthStar Rx LLC)
FDA approved an original application for norepinephrine bitartrate injections from NorthStar Rx LLC, a generic vasopressor indicated for rai…
-
FDA approval · 2022-09-15FDA Approved: NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)
FDA approves norepinephrine bitartrate in sodium chloride for injection under an original application by WG Critical Care, LLC, a vasopresso…
-
FDA approval · 2021-06-14FDA Approved: EPHEDRINE SULFATE — Original Application (Eugia US LLC)
FDA approved the original application for Ephedrine Sulfate by Eugia US LLC, authorizing its marketing as a generic drug. The product is use…
-
FDA approval · 2021-01-29FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved norepinephrine bitartrate injection from Sun Pharmaceutical Industries as an original-application generic product.
-
FDA approval · 2020-11-13FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved the original application for Phenylephrine Hydrochloride from Eugia US LLC (a generic drug product).
-
FDA approval · 2020-09-28FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for norepinephrine bitartrate from Meitheal Pharmaceuticals Inc. to market this generic product.
-
FDA approval · 2020-08-12FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Civica, Inc.)
FDA approved Civica, Inc.'s supplemental application for norepinephrine bitartrate (ANDA 211359).
-
FDA approval · 2020-06-05FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Gland Pharma Limited)
FDA approved the original application for phenylephrine hydrochloride from Gland Pharma Limited as a generic product. This approval enables …
-
FDA approval · 2019-06-19FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Phenylephrine Hydrochloride from Hikma Pharmaceuticals USA, authorizing changes to labeling …
-
FDA approval · 2019-01-31FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved an Original Application for Phenylephrine Hydrochloride from Sandoz Inc, enabling the marketing of this generic product.
-
FDA approval · 2019-01-29FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's Original Application for phenylephrine hydrochloride as a generic drug product.
-
FDA approval · 2018-11-07FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic norepinephrine bitartrate injection (Original Application) as a vasopressor for treati…
-
FDA approval · 2018-10-04FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Mylan Institutional LLC)
FDA approved Mylan Institutional LLC's original application for norepinephrine bitartrate injections (generic) as a vasopressor to treat lif…